Article
Executive Resource
Insight Hub
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
WebinarIn today’s turbulent marketplace, fluctuating valuations can create challenges for those involved in M&A activity in the energy industry. Many factors may affect energy operations from oil prices, to new technology, to heightened regulation and so forth. For these reasons and more, it is essential to enhance your understanding of how these factors impact your value.
Written for Trust & Estates, Weaver’s Will Frazier discusses the results of the Fifth Circuit opinion in Nelson v Commissioner.
Get ahead of the curve by looking back at emerging trends in 2021 that are likely to impact health care valuation in 2022 and beyond.
Read about some of the impacts of increased hospital employment and accelerated retirements resulting in shortages of replacement physician investors.
Published in WealthManagement.com, Weaver’s Managing Director in Valuation Services, William Frazier, ASA, provides insight on the continuation of the family limited partnership (FLP) valuation discount.
PodcastTyler Ridley joined this episode of Weaver: Beyond the Numbers podcast with Weaver hosts Howard Altshuler and Rob Nowak to discuss the rebound and current financial state of the biopharma and med tech industries.
The urgent care industry has been experiencing accelerated patient visit volume into 2021, continuing trends started in 2020.
Many business valuations begin with calculating a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization). In health care, however, valuators should deliberate just when and how to apply general valuation EBITDA transaction multiples for fair market value opinions.
Commentary from publicly traded Managed Care Organizations (MCOs) regarding their insurance spend expectations can be an excellent source of macroeconomic data for health care valuation professionals when projecting performance for provider entities.
Questions about the shelf life of a fair market value (FMV) opinion can arise when the parties seek certainty about compliance with government regulations or wish to maintain arrangements that are financially viable to all parties.
Professionals tasked with performing health care appraisals still face circumstantial challenges when performing their work fifteen months after the pandemic began. While a lot has changed, the basics of valuation have not.
Transactions for large hospice providers are yielding historically high multiples of EBITDA and revenue.